Platelet Glutathione Peroxidase Activity in Long-Term Total Parenteral Nutrition With and Without Selenium Supplementation

Selenium (Se) is not routinely included in total parenteral nutrition (TPN) solution; thus, patients receiving long-term TPN may be at risk of Se deficiency, which may cause fatal cardiomyopathy. Platelet glutathione peroxidase (GSH-Px) activity, as well as Se levels and GSH-Px activity in plasma and erythrocytes during prolonged TPN, was measured in six patients with chronic gastrointestinal disease. During the time course of TPN, Se administration was discontinued for 12 weeks, and then resupplemented for another 12 weeks. Before the study period, all Se indices had been maintained within the normal range. After discontinuation of Se supplementation, a significant decrease in platelet GSH-Px activity was observed after 1 week (from 64 ± 7 [mean ± SD] to 39 ± 5 U/g of protein). After resupplementation, it increased after 1 week (from 44 ± 9 to 65 ± 10 U/g of protein). Plasma Se indices significantly changed within 3 weeks after withdrawal and reintroduction of Se (Se: from 136 ± 28 to 75 ± 14 and from 61 ± 22 to 125 ± 33 μg/L; GSH-Px: from 236 ± 50 to 140 ± 36 and from 128 ± 32 to 220 ± 64 U/L). Erythrocyte Se indices showed no significant changes during the study period. The results demonstrate that platelet GSH-Px activity is the most sensitive index of Se status in TPN patients. (Journal of Parenteral and Enteral Nutrition 16:54-58, 1992)